[DOI] [PubMed] [Google Scholar] 86.Ussher JR, Campbell JE, Mulvihill EE, Baggio LL, Bates HE, McLean BA, Gopal K, Capozzi M, Yusta B, Cao X, et al
Energy expenditure drops, and the caloric gap narrows, slowing further weight loss
First in vitroin silico analysis for the determination of antimicrobial and antioxidant properties of 2-(4-methoxyphenylamino)-2-oxoethyl methacrylate and p-acetamide
Liraglutide , taken daily: FDA-approved under the brand name Saxenda for chronic weight management alongside diet and exercise in adults with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with a weight-related medical condition or in children ages 12 years and older with obesity who weigh at least 132 pounds
Furthermore, L-Carnitine has been shown to have antioxidant properties, helping to mitigate oxidative stress that can occur during intense exercise
Most studies used a placebo as the control treatment, though a few compared GLP-1RAs with other medications or behavioral therapies